SoFi Gains $1.2 Billion After Crypto-Led Surge Leaves Shares 7% Below Wall Street Estimate
SAN FRANCISCO, August 21, 2026, 10:50 EDT — Shares of SoFi Technologies climbed 5.27% to $18.86 by Friday morning, increasing its market capitalization by…
Market intelligence
Fast, evidence-led coverage of the companies and events moving global markets.
All coverage
SAN FRANCISCO, August 21, 2026, 10:50 EDT — Shares of SoFi Technologies climbed 5.27% to $18.86 by Friday morning, increasing its market capitalization by…
Friday’s rally moved the stock above six current Hold or Sell targets. Piper Sandler’s new $22 target still leaves 16.6% upside.
| Measure | Result | YoY |
|---|---|---|
| GAAP net revenue | $1.219B | +43% |
| Net income | $156.6M | +61% |
| Adjusted EBITDA | $357.8M | +44% |
| Loan originations | $14.8B | Record |
| Total products | 24.4M | +42% |
| Fee-based revenue | $472.3M | 39% of revenue |
What the market is pricing: bank-funded lending growth plus future blockchain and payments fees.
What can break: a bitcoin reversal, delayed U.S. crypto rules, higher credit losses, or weaker deposit growth with a falling net interest margin.
Shares of Robinhood Markets, Inc. rose 11.29% on Friday amid renewed optimism over crypto policy. By mid-morning, the rally had boosted its equity value…
| What changed | Current signal | Proof still needed |
|---|---|---|
| Crypto policy | White House pressure for Clarity Act | Passage and durable SEC/CFTC rules |
| Tokenized equities | Public chain + 120-country rollout | Volume, fees and compliant custody |
| Core platform | $21.7B quarterly net deposits | Cross-sell without margin erosion |
| Valuation | 46.8× earnings | Growth fast enough to defend premium |
Strategy Inc., previously known as MicroStrategy, rose 6.2% to $119.35 in early Friday trade. The rally in Bitcoin to $79,463 boosted the value of…
Market snapshot: August 21, 2026, 10:37 EDT
Bitcoin intraday high: August 21, 2026
| Metric | Latest | Read-through |
|---|---|---|
| MSTR shares sold, Aug. 10–16 | 3,458,866 | New common supply |
| Net ATM proceeds | $333.7m | Liquidity and preferred support |
| Bitcoin bought in period | 0 | Accumulation remains paused |
| Remaining MSTR ATM capacity | $21.70bn | Material future dilution capacity |
| Q2 revenue growth | +6.9% | Software base is growing slowly |
Sources: Strategy Form 8-K filed August 17, 2026; Strategy Q2 release; StockAnalysis/S&P Global; Investor's Business Daily; historical closes from Yahoo Finance. Holding values are estimates using 840,447 BTC and may differ from accounting fair value. Price targets are forecasts, not guarantees.
MARA Holdings, Inc. was up 3.3% at $11.52 as of 10:28 EDT on Friday. The stock's rally over two sessions amounted to a 19.4%…
| Two-session bridge | Estimate |
|---|---|
| MARA equity value added | $722M |
| Gain on June BTC balance | $279M |
| Value above BTC mark | $443M |
| Equity gain / BTC mark | 2.6× |
| Metric | Q2 2026 | YoY |
|---|---|---|
| Revenue | $174.9M | −27% |
| Energized hashrate | 70.3 EH/s | +22% |
| BTC produced | 2,422 | +3% |
| Energy cost / BTC | $38,690 | +15% |
Investor read: only about 39% of MARA’s estimated two-day value gain is explained by marking its June Bitcoin balance higher. The rest is a provisional premium for power, AI/HPC leases and operating leverage. A signed tenant would validate it. A delay would expose it.
MENLO PARK, California, August 21, 2026, 10:20 EDT — Robinhood recorded an increase of $11.7 billion as investors focus on the potential for tokenization,…
The rally prices a regulation-and-tokenization option on top of a diversified earnings base. Crypto was only 7.6% of second-quarter revenue.
| Measure | Target | Upside |
|---|---|---|
| Consensus: Buy | $119.82 | +10.9% |
| DBS • Buy | $120 | +11.0% |
| Goldman Sachs • Buy | $118 | +9.2% |
| Cantor • Overweight | $115 | +6.4% |
| Barclays • Overweight | $105 | -2.8% |
| Activity | Scale | Signal |
|---|---|---|
| Equity notional, Q2 | $956B | +85% YoY |
| Options contracts, Q2 | 774M | +50% |
| Event contracts, Q2 | 13.6B | >10× |
| Crypto notional, Q2 | $40B | $22B from Bitstamp |
| On-chain equity volume, 2026 | $9B | Small base; +800% YTD reported |
Intel Corporation shares remained below their $95 offering price on Friday. The stock traded at $91.92 at 09:44 EDT, down 0.2%. That left buyers…
| Metric | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $16.1B | $12.9B | +25% |
| Non-GAAP gross margin | 41.8% | 29.7% | +12.1 pts |
| Non-GAAP operating margin | 17.2% | −3.9% | +21.1 pts |
| Non-GAAP EPS | $0.42 | −$0.10 | Positive |
| Operating cash flow | $7.0B | — | Net raise = 2.8× |
NVIDIA Corporation is set for a potential $316 billion shift in market value next week. Options data indicates shares could move 6% following Wednesday's…
| Commitment | Scale | Investor question |
|---|---|---|
| Partner infrastructure platforms | >$500B target | How quickly does funding convert to demand? |
| Ohio PORTS campus | 4.25 IT-GW initial | Does credit support amplify balance-sheet risk? |
| Nvidia initial investment | $1.5B | Is order pull-through worth the exposure? |
Tesla Inc. faced a fresh autonomy-data test on Friday. Video published this week showed an unsupervised Austin robotaxi driving through flexible traffic bollards. No…
Tesla is broadening its offering of autonomous rides, though the data set for incidents is difficult to verify. A single bollard incident video provides limited insight. With current valuation levels, consistent and transparent reporting is particularly important.
| Firm | View | Target | Vs. price |
|---|---|---|---|
| JPMorgan | Neutral | $475 | +37.6% |
| Morgan Stanley | Equal-weight | $400 | +15.9% |
| Jefferies | Hold | $350 | +1.4% |
| Wells Fargo | Underweight | $130 | −62.3% |
| 49-analyst average | Overweight | $374.27 | +8.4% |
NEW YORK, August 21, 2026, 09:32 EDT — Nu Holdings Ltd. has seen roughly $4.9 billion in market value erased since the close following…
The multiple compression says investors want proof that lower credit costs can persist.
| Metric | Result |
|---|---|
| Net income | $1.1bn · +49% |
| ROE | 33% |
| Risk-adjusted NIM | 12.4% · +290bp QoQ |
| Credit portfolio | $39.4bn · +37% |
| Customers | 139m |
| Indicator | Q2 signal |
|---|---|
| 15–90 day NPL | 4.8% · −16bp |
| 90+ day NPL | 6.9% · +35bp |
| Cost of credit | $1.7bn · −9% QoQ |
| Efficiency ratio | 19.5% vs 17.6% |
| Mexico loan/deposit | 35% |
| Analyst / firm | Call | Target | Upside / downside |
|---|---|---|---|
| Thiago Batista · UBS | Buy | $18 | +26.7% |
| Jorge Kuri · Morgan Stanley | Buy | $21 | +47.8% |
| James Friedman · Susquehanna | Hold | $16 | +12.6% |
| Mario Pierry · BofA | Sell | $10 | −29.6% |
| Kyle Peterson · Needham | Buy | $19 | +33.7% |
Near term: can $14.21 hold after the open?
Credit: 90+ NPL must stabilize.
Upside: Mexico monetisation and a durable 12%+ risk-adjusted NIM.
Werewolf Therapeutics, Inc. will merge with privately owned Ambros Therapeutics. The transaction gives Werewolf a valuation of $47.5 million. That is roughly 127% higher…
| Werewolf cash, June 30 | $22.0M |
| Werewolf debt | $0 |
| Ambros implied value | $500M |
| Combined runway | 1H 2029 |
| Shareholder / Nasdaq approval | Required |
| Final net cash | Must exceed $0 |
| Phase 3 outcome | Binary |
| CVR payout | May be zero |
Capricor Therapeutics faces a renewed legal overhang after law firms on Thursday repeated a September 28 lead-plaintiff deadline in a federal securities-fraud case. The…
Securities-fraud case adds a legal layer to a regulatory binary.
Analysis and efficacy concerns surface.
9-3 against efficacy evidence.
FDA willing to review 24-month amendment.
Lead-plaintiff motion due.
Static runway: $237.9m cash ÷ $42.9m Q2 operating expenses = 5.5 quarters. This is a simple ratio, not management guidance.
| Firm | Date | Rating | Target |
|---|---|---|---|
| Cantor Fitzgerald | Aug. 14 | Overweight | $28 |
| B. Riley | Jul. 31 | Hold | $5 |
| Jones Trading | Jul. 30 | Hold | — |
| Piper Sandler | Jul. 30 | Neutral | $2 |
| H.C. Wainwright | Jul. 30 | Neutral | — |
The lawsuit mirrors the same statistical-analysis dispute that drove the stock collapse. A revised action date would clarify how much regulatory optionality remains.
A new clinical-trial requirement could extend losses and consume the cash buffer. Adverse discovery in the securities case may add cost and disclosure risk. Faster spending would shorten the 5.5-quarter static runway.
Shares of Webster Financial Corporation last traded at $77.57 on Wednesday, before Banco Santander finalized its $12.2 billion acquisition on Thursday, removing Webster from…
| Revenue | $740.0M |
| Adjusted EPS | $1.60 |
| Deposits | $70.3B · +6% YoY |
| Loans | $57.9B · +7.8% YoY |
| Net interest margin | 3.26% · −18 bp YoY |
| CET1 ratio | 11.69% preliminary |
| Nonperforming-loan ratio | 0.74% · down from 1.00% |
BioNTech SE retained the majority of a $5.1 billion rise in market value following positive data from a competing cancer vaccine. Shares ended Thursday…
Moderna and Merck validated the category. BioNTech kept most of the sympathy gain, compressing the gap to the existing analyst consensus.
| Program | Stage | Evidence | Investment read |
|---|---|---|---|
| Moderna/Merck intismeran | Phase 3 | Positive topline in 1,137 resected melanoma patients | Direct category validation |
| BioNTech BNT111 | Phase 2 | Positive response-rate endpoint vs historical control | Promising, not registrational proof |
| BioNTech autogene cevumeran | Phase 2 | Missed primary PFS endpoint in advanced melanoma | Platform outcomes can diverge |
Sources: Yahoo Finance, Reuters, BioNTech Q2 2026, S&P Global analyst poll via StockAnalysis. Market-value estimate uses the latest reported 251.2m shares. Analyst targets and consensus are estimates, not guarantees.
NEW YORK, August 21, 2026, 08:21 EDT — Ambev S.A. saw high premarket activity in the U.S., ending Thursday’s session at $2.83 as 107.9…
Operating cash flow rose 54.5%, while normalized profit increased 23.3%.
R$20.15B revenue was 3.25% below the R$20.83B displayed estimate.
Follow-through matters more than the one-day volume spike.
Walmart Inc. saw its market value drop by approximately $83.2 billion on Thursday, as shares declined 9.15% to $103.84. This drop followed an earnings…
| Retailer | Close | Day | Market cap | Trailing P/E |
|---|---|---|---|---|
| Walmart | $103.84 | -9.15% | $826.37bn | 40.25x |
| Costco | $933.51 | -2.45% | $413.99bn | 46.96x |
| Target | $158.25 | -0.47% | $71.88bn | 16.50x |
| Firm | Action | View | Target |
|---|---|---|---|
| Gordon Haskett | Downgrade | Accumulate | — |
| Oppenheimer | Downgrade | Cautious | — |
| Guggenheim | Reiterate | Buy | $135 |
| DA Davidson | Reiterate | Buy | $150 |
| 38-analyst consensus | Snapshot | Moderate Buy | $137.44 |
Space Exploration Technologies Corp. is set for a new supply challenge after its stock dropped 4.05% on Thursday. Up to 319 million insider shares…
Market data captured August 21, 2026, 08:01:21 EDT / 14:01:21 CEST. Nasdaq cash market: pre-open. Price and volume refer to the August 20 close.
AI infrastructure used $15.8bn, or 86% of quarterly capital expenditure.
At $134, the eligible tranche is worth about $42.7bn. Eligibility does not mean immediate sale.
| Analyst | View | Target | Upside |
|---|---|---|---|
| Cantor | Overweight | $246 | 83.6% |
| UBS | Buy | $210 | 56.7% |
| Mizuho | Outperform | $200 | 49.3% |
| BofA | Buy | $235 | 75.4% |
| Near-term pressure | Longer-term support |
|---|---|
| Starship upper-stage catch delayed by months | U.S. seeks 1,000 annual launches by 2030 |
| 319m shares newly eligible | Q2 revenue up 92% |
| Close 40.6% below 52-week high | $14.1bn cloud-services contracts |
Volume above the 120.2m-share average without a deeper price break would show that buyers are absorbing the unlock. Renewed selling toward the $104.83 low would put capital spending and execution back in control of the valuation.
Sources: Yahoo Finance most-active screen, SpaceX August 4 current report, MarketWatch, Reuters, Wall Street Journal and cited analyst actions. Dollar figures are U.S. dollars.